Terazosin
- Product NDC
- 53217-212
- 11-digit product format
- 532170212
- Labeler code
- 53217
- Product ID
- 53217-212_9bce3e50-1bf2-4d35-8edf-00d5784a1622
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2004-12-20
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53217-212-30 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
| 53217-212-60 | Terazosin | 60 in 1 BOTTLE | CAPSULE | 60 | | 1 |
| 53217-212-90 | Terazosin | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53217-212 | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | Legacy NDC, 3 package rows | 20160727_dfcd267e-a965-4942-987a-766a7305f421.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 53217-212-30 | 53217021230 | 30 in 1 BOTTLE | Historical |
| 53217-212-60 | 53217021260 | 60 in 1 BOTTLE | Historical |
| 53217-212-90 | 53217021290 | 90 in 1 BOTTLE | Historical |